Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 374 participants.
Also called NCT06013020
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 374 participants
- Sponsor
- Registry
-
NCT06013020
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06013020. Randomized; no masking; primary purpose prevention. Start 2024-04-01 (anticipated); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus
- Condition
- STEMI - ST Elevation Myocardial Infarction
- Intervention (Drug)
- NOAC+DAPT
- Intervention (Drug)
- DAPT
- Lead sponsor
- Zunyi Medical College
Record details
- Record id
cardio:ct-nct06013020- Content hash
cd1ba42f10a84c5664ddd1285f0cb270baea29edb5f8cfda64ad7fe4935b7933